Avacta Group Share News (AVCT)
AVCT Share
AVCT Share
AVCT Share
AVCT Share
AVCT
AVCT Share
AVCT Level 2
AVCT Live
AVCT Broker
AVCT Directors
AVCT Financial
AVCT
AVCT Short
AVCT
Last checked at -
(Sharecast News) - Biotherapeutics company Avacta Group has entered into an agreement with Abingdon Health for the manufacture of its saliva-based rapid SARS-CoV-2 antigen test, it announced on Wednesday, as part of its ongoing expansion of manufacturing capacity.
Read more
Avacta Expands Development Agreement With LG Chem Life Sciences
Read moreIN BRIEF: Avacta Not Involved With Medusa 19's Covid Antibody Test
Read moreIN BRIEF: Avacta Names New Life Sciences Chief Development Officer
Read more(Sharecast News) - Avacta Group has entered into a collaboration with the Liverpool School of Tropical Medicine (LSTM), it announced on Friday, to clinically validate the rapid saliva-based coronavirus antigen test it is developing with Cytiva.
Read moreUK WINNERS & LOSERS SUMMARY: Hikma Shines After Raising Sales Guidance
Read moreAvacta Collaborates With Liverpool School For Covid-19 Test Validation
Read moreIN BRIEF: Avacta Appoints BBI Solutions To Manufacture Covid Test Kit
Read more(Sharecast News) - Biotechnology company Avacta on Thursday appointed BBI Solutions as a manufacturing partner for the development of its rapid SARS-CoV-2 antigen test.
Read moreIN BRIEF: Avacta Expands Partnership With Daewoong Pharmaceutical
Read more(Sharecast News) - Biotherapeutics and reagents developer Avacta Group announced an expansion of its collaboration and license agreement with Daewoong Pharmaceutical and AffyXell Therapeutics - the joint venture established in South Korea by the two companies - to develop stem cell treatments on Wednesday.
Read moreUK TRADING UPDATE SUMMARY: Virus Hits Mears But Tristel Gets Boost
Read more(Sharecast News) - Avacta Group has started work with the UK government's 'CONDOR' programme, it announced on Wednesday, to evaluate and clinically validate the high throughput Covid-19 bead-assisted mass spectrometry laboratory assay, developed with Adeptrix.
Read moreAvacta Partners With Integumen To Detect Covid-19 In Waste Water
Read more(Sharecast News) - Biotherapeutics company Avacta Group has entered into a collaboration with its AIM peer Integumen, it announced on Monday, to evaluate recently-generated Affimer reagents that bind the SARS-CoV-2 spike protein for the detection of the coronavirus in wastewater, to provide a real-time alert system to warn of localised Covid-19 outbreaks.
Read more
Last checked at